MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS (MDS/MPN)

Clinical trials for MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS (MDS/MPN) explained in plain language.

Never miss a new study

Get alerted when new MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS (MDS/MPN) trials appear

Sign up with your email to follow new studies for MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS (MDS/MPN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill aims to tame rare blood cancers in early trial

Disease control Recruiting now

This study tests an experimental daily pill, JBI-802, in about 30 adults with certain blood cancers (MPN or MDS/MPN) that cause too many platelets. The goal is to check safety and see if the drug can lower platelet counts and shrink the cancer. Participants take the pill for up t…

Matched conditions: MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS (MDS/MPN)

Phase: PHASE1, PHASE2 • Sponsor: Jubilant Therapeutics Inc. • Aim: Disease control

Last updated Jun 17, 2026 04:13 UTC

MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS (MDS/MPN)

Get alerted when new MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS (MDS/MPN) trials appear

New pill aims to tame rare blood cancers in early trial